← Evidence map

ArticleAnnals of hematology2021

Compassionate use of glasdegib in combination with low-dose cytarabine for relapsed, refractory acute myeloid leukemia or high-risk myelodysplastic syndrome.

Márcio Tavares et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33001280